A survey describing the use of complementary therapies and medicines by women attending a family planning clinic

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Smith, Caroline A ^a   Bateson, Deborah J ^b   Weisberg, Edith ^b  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b New South Wales Department of Planning and Infrastructure   (Australia)

Author keywords

Complementary therapies and medicines; Family planning; Reproductive health; Survey; Women's health

Indexed keywords

VITAMIN;

ADULT; ALTERNATIVE MEDICINE; AROMATHERAPY; ARTICLE; ATTITUDE; AUSTRALIA; CHINESE MEDICINE; CLINICAL EFFECTIVENESS; CROSS-SECTIONAL STUDY; DECISION MAKING; FAMILY PLANNING; FEMALE; HEALTH CARE UTILIZATION; HEALTH PRACTITIONER; HEALTH SURVEY; HERBAL MEDICINE; HUMAN; LOGISTIC REGRESSION ANALYSIS; SAFETY;

ADOLESCENT; ADULT; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; FAMILY PLANNING SERVICES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; QUESTIONNAIRES; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84883650168     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-224     Document Type: Article

References (23)

1. Lunny CA, Fraser SN. The use of complementary and alternative medicines among a sample of Canadian menopausal-aged women. J Midwifery Womens Health 2010, 55:335-343.
2. Rayner JA, Willis K, Burgess R. Women's use of complementary and laternative medicine for fertility enhancement: a review of the literature. J Altern Complement Med 2011, 17(8):685-690.
3. Adams J, Sibbritt D, Lui CW. The use of complementary and alternative medicine during pregnancy: a longitudinal study of Australian women. Birth 2011, 38:200-206.
4. Yu SM, Ghandour RM, Huang ZJ. Herbal supplement use among US women. J Am Med Womens Assoc 2004, 59:17-24.
5. Gaffney L, Smith CA. The views of pregnant women towards the use of complementary therapies and medicines. Birth Issues 2004, 13:43-50.
6. Nordeng H, Havnen GC. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf 2004, 13:371-380.
7. Lapi F, Vannacci A, Moschini M, et al. Use, attitudes and knowledge of complementary and alternative drugs (CADs) among pregnant women: a preliminary survey in Tuscany. Evid Based Complement Alternat Med 2010, 7:477-486.
8. Holst L, Nordeng H, Haavik S. Use of herbal drugs during early pregnancy in relation to maternal characteristics and pregnancy outcome. Pharmacoepidemiol Drug Saf 2008, 17:151-159.
9. Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS. Insurance coverage, medical conditions, and visits to alternative medicine providers: results of a national survey. Arch Intern Med 2002, 162(3):281-287.
10. Williamson M, Tudball J, Toms M, Garden F, Grunseit A. Information use and needs of complementary medicines users 2008, Sydney: National Prescribing Service.
11. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in unconventional medicine use in the United States 1990-1997. JAMA 1998, 280:1569-1575.
12. Schwarz UI, Buschel B, Kirch W. Unwanted pregnancy on self medication with St John's wort despite hormonmal contraception. Br J Clin Pharmacol 2003, 55:112-113.
13. Hall SD, Wanf Z, Shiew-Mei H, et al. The interaction between St John's wort and an oral contraceptive. Clin Pharmacol Ther 2003, 74:525-535.
14. Pfunder A, Schiesser M, Gerber S, et al. Interaction of St John's wort with low dose oral contraceptive therapy: a randomised controlled trial. Br J Clin Pharmacol 2003, 56:683-690.
15. Murphy PA, Kern SE, Stanczyk FZ, WEsthoff CL. Interaction of St John's wort with oral contraceptive: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception 2005, 71:402-408.
16. Royal College of Obstetricians and Gynaecologists Drug interaction with hormonal contraception 2012, London: Faculty of Sexual and Reproductive Healthcare. Clinical Effectiveness Unit, Royal College of Obstetricians and Gynaecologists.
17. Therapeutic Goods Administration An overview of the regulation of complementary medicines in Australia 2013, http://www.tga.gov.au/industry/cm-basics-regulation-overview.htm, Therapeutic Goods Administration.
18. Robinson A, Cooper S. Trusted information sources: the preferred option for complementary and alternative medicine users. Complement Health Pract Rev 2007, 12:120.
19. Stankiewicz M, Smith C, Alvino H, Norman R. The use of complementary medicine and therapies by patients attending a reproductive medicine unit in South Australia: a prospective survey. Aust New Zeal J Obstet Gynaecol 2007, 47(2):145-149.
20. Xue C, Zhang A, Lin V, Da Costa C, Story D. Complementary and alternative medicine use in Australia: a national population based survey. J Altern Complement Med 2007, 13:643-650.
21. Harrigan JT. Patient disclosure of the use of complementary and alternative medicine to their obstetrician/gynaecologist. J Obstet Gynaecol 2011, 31(1):59-61.
22. Wieland LS, Manhiemer E, Berman BM. Development and classification of an operational definition oif complementary and alternative medicine for the Cochrane collaboration. Altern Ther Health Med 2011, 17(2):50-59.
23. World Health Organisation Traditional medicine strategy 2002-2005 2002, Geneva: World Health Organisation, World Health Organisation.